<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Clin Microbiol Antimicrob</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann. Clin. Microbiol. Antimicrob</journal-id>
      <journal-title-group>
        <journal-title>Annals of Clinical Microbiology and Antimicrobials</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1476-0711</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25106550</article-id>
      <article-id pub-id-type="pmc">4236555</article-id>
      <article-id pub-id-type="publisher-id">s12941-014-0034-4</article-id>
      <article-id pub-id-type="doi">10.1186/s12941-014-0034-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Type II and type IV topoisomerase mutations in clinical isolates of <italic>Morganella morganii</italic> harbouring the <italic>qnr</italic>D gene</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Nasri Yaiche</surname>
            <given-names>Mariem</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>mariem_nasri@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Denden Rafraf</surname>
            <given-names>Ikbel</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>denden_ikbel@yahoo.fr</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Guo</surname>
            <given-names>Qinglan</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>qinglanguo@fudan.edu.cn</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Mastouri</surname>
            <given-names>Maha</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>mastourimaha@yahoo.fr</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Aouni</surname>
            <given-names>Mahjoub</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>aouni_mahjoub2005@yahoo.fr</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Wang</surname>
            <given-names>Minggui</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>mgwang@fudan.edu.cn</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Faculty of Sciences, Bizerta Carthage University, Bizerta, Tunisia</aff>
      <aff id="I2"><label>2</label>Laboratory of Biologically Active Substances and Communicable Diseases (LR99ES27), Monastir University, Monastir, Tunisia</aff>
      <aff id="I3"><label>3</label>Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China</aff>
      <aff id="I4"><label>4</label>Laboratory of Microbiology, Fattouma Bourguiba University Hospital, Monastir, Tunisia</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <volume>13</volume>
      <fpage>34</fpage>
      <lpage>34</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>7</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Nasri Yaiche et al.; licensee BioMed Central Ltd</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Nasri Yaiche et al.; licensee BioMed Central Ltd</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.ann-clinmicrob.com/content/13/1/34"/>
      <abstract>
        <sec>
          <title>Introduction</title>
          <p>The aim of this study was to show the emergence of the <italic>qnrD</italic> gene among fluoroquinolone-resistant&#x2009;<italic>Morganella morganii</italic>&#x2009;isolate. The occurrence of mutations in DNA gyrase (<italic>gyrA</italic> and <italic>gyrB</italic>) and topoisomerase IV (<italic>parC</italic>,<italic>parE</italic>) genes was also investigated in this strain.</p>
        </sec>
        <sec>
          <title>Methodology</title>
          <p>95 clinical Enterobacteria were screened for harbouring the <italic>qnrD</italic> gene. The clinical isolate of <italic>M. morganii</italic> was recovered from urine from a patient hospitalized in the urology unit at Fattouma Bourguiba Hospital, Tunisia. Antibiotic susceptibility was tested with the agar disk diffusion method. Quinolone susceptibility was studied with microbroth dilution technique. The investigations of plasmid mediated quinolone resistance (PMQR) and topoisomerases mutations were performed by polymerase chain reaction and nucleotide sequencing.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>This isolate showed high level of resistance to quinolones. The MIC with microbroth dilution technique was 512 &#x3BC;g/ml for norfloxacin, 256 &#x3BC;g/ml for ofloxacin and ciprofloxacin and 64&#x3BC;g/ml for levofloxacin.</p>
          <p>This strain was found to harbour the quinolone resistance determinant <italic>qnrD.</italic> In addition, this strain harboured two new <italic>gyrB</italic> mutations (S463A, S464Y) and one <italic>parC</italic> mutation (S80I).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This is the first report in Tunisia of <italic>qnrD</italic> determinant and tow new <italic>gyrB</italic> muations in <italic>M. morganii</italic>. The nosocomial infection due to this <italic>proteeae</italic> invites further study of its epidemiologic evolution.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Morganella morganii</kwd>
        <kwd>Quinolone resistance</kwd>
        <kwd>Topoisomerase mutation</kwd>
        <kwd>qnrD</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>The first <italic>qnr</italic> gene was observed in the late 1990s and described as a plasmid-mediated quinolone resistance gene (PMQR). Since that, five types of <italic>qnr</italic> genes have been reported: <italic>qnrA</italic>, <italic>qnrB</italic>, <italic>qnrC</italic>, <italic>qnrD</italic>, and <italic>qnrS</italic>. Their sequences are deposited at the following website (<ext-link ext-link-type="uri" xlink:href="http://www.lahey.org/qnrStudies/">http://www.lahey.org/qnrStudies/</ext-link>). Most were observed in <italic>Enterobacteriaceae</italic>, located on large conjugative multi-resistant plasmids, such as pMG252 seen in the original <italic>qnrA1</italic>-positive strain [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>The <italic>qnrD</italic> gene was first described in 2009 on a 4270&#xA0;bp plasmid present in a human clinical isolate of <italic>Salmonella enterica</italic> serovar <italic>Kentucky</italic> and three <italic>Salmonella enterica</italic> serovar <italic>Bovismordificans</italic> isolates from China [<xref ref-type="bibr" rid="B2">2</xref>]. Since this report, <italic>qnrD</italic> was found in <italic>Escherichia coli</italic>[<xref ref-type="bibr" rid="B3">3</xref>], <italic>M. morganii</italic>[<xref ref-type="bibr" rid="B4">4</xref>], <italic>P. Mirabilis</italic>[<xref ref-type="bibr" rid="B4">4</xref>],[<xref ref-type="bibr" rid="B5">5</xref>], <italic>Pseudomonas aeruginosa</italic>[<xref ref-type="bibr" rid="B5">5</xref>] and <italic>Providencia rettgeri</italic>[<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>We describe the new <italic>gyrB</italic> and <italic>parC</italic> mutations in a clinical isolate of <italic>M. morganii</italic> harbouring the rare <italic>qnrD gene that is first reported in Tunisia</italic>.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Material and methods</title>
      <sec>
        <title>Case presentation</title>
        <p>On 22 November 2012, a 76-years old male presented to the urology department with hematuria and burning micturition that were neglected by the patient since six months. On presentation, he was not febrile with normal vital signs and negative urine culture.</p>
        <p>The ultrasonography shows a bladder of budding aspect, bifocal with long axis (3&#xA0;cm). The histopathology revealed urothelial carcinoma infiltrating high-grade bladder (II pTa). On 30/11/2012, underwent a transurethral resection of bladder tumor. A double-current probe 18 c was also introduced.</p>
        <p>On 19/01/2013 the patient presented an acute pyelonephritis and the urine culture showed the presence of quinolone resistant <italic>M. morganii.</italic> The empiric antibiotic therapy consisted of three doses a day of 2_g Ampicillin during 4&#xA0;days. Urine culture subsequently yielded <italic>M.morganii</italic>. The antibiotic regime was then replaced with three doses a day of cefoxitin 1_g during one week. After this, the urine culture was negative but the haematuria still existed.</p>
      </sec>
      <sec>
        <title>Bacterial strain</title>
        <p><italic>M. morganii</italic> was isolated from urine and identified using the Vitek 2 identification system (bioM&#xE9;rieux, Marcy l&#x2019;Etoile, France). The antimicrobial susceptibilities of the <italic>M. morganii</italic> isolate were determined on Mueller-Hinton agar by the standard disk diffusion procedure as described by the Antibiogram Committee of the French Society for Microbiology (<ext-link ext-link-type="uri" xlink:href="http://www.sfm.asso.fr">http://www.sfm.asso.fr</ext-link>). The microbroth dilution technique was used to determine the minimal inhibitory concentrations (MIC) for norfloxacin, ofloxacin, ciprofloxacin and levofloxacin.</p>
      </sec>
      <sec>
        <title>PMQR screening</title>
        <p>The <italic>qnrA, qnrB, qnrS, qnrC, qnrD, aac-Ib</italic>, and <italic>qepA</italic> genes were detected by PCR with the primer sets as described previously [<xref ref-type="bibr" rid="B2">2</xref>],[<xref ref-type="bibr" rid="B7">7</xref>]-[<xref ref-type="bibr" rid="B10">10</xref>].</p>
        <p><italic>QnrD</italic> primers were used also for the clinical survey of <italic>qnrD</italic> gene in other quinolone resistance <italic>Enterobacteriacae</italic> (n&#x2009;=&#x2009;95) collected from October 2010 to June 2013: <italic>Klebsiella pneumoniae</italic> (n&#x2009;=&#x2009;59), <italic>Enterobacter cloaceae</italic> (n&#x2009;=&#x2009;17), <italic>Citrobacter freundii</italic> (n&#x2009;=&#x2009;9), <italic>Salmonella spp</italic> (n&#x2009;=&#x2009;6), <italic>Providencia rettgerii</italic> (n&#x2009;=&#x2009;3), <italic>M. morganii</italic> (n&#x2009;=&#x2009;1).</p>
      </sec>
      <sec>
        <title>Conjugation</title>
        <p>The transferability of <italic>qnrD</italic> gene between the <italic>M. morganii</italic> isolate and the <italic>E. coli</italic> J53Az<sup>r</sup> recipient were carried out in LB broth. Cultures of donor and recipient cells in logarithmic phase (0.5&#xA0;ml of each) were added to 4&#xA0;ml of fresh LB broth and incubated overnight without shaking. Transconjugants were selected on Trypticase soy agar (TSA) plates containing sodium azide (100&#xA0;&#x3BC;g/ml; Sigma Chemical Co., St. Louis, Mo.) for counterselection and gentamicin (10&#xA0;&#x3BC;g/ml) to select for plasmid-encoded resistance.</p>
      </sec>
      <sec>
        <title>Detection of mutations in the topoisomerase II and IV genes</title>
        <p>The quinolone resistance-determinant regions (QRDRs) of <italic>gyrA</italic>, <italic>gyrB</italic>, <italic>ParC</italic> and <italic>parE</italic> was amplified as described previously [<xref ref-type="bibr" rid="B11">11</xref>]. Products resulting from amplifications were subjected to sequencing. Analysis and comparison of nucleotide and amino acid sequence data were carried out using Lasergene software (version 7.1; DNASTAR, Wisconsin, USA), and programs available from the national Center for Biotechnology Information (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>).</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Antibiotic susceptibility of M. morganii</title>
        <p>The clinical strain of <italic>M. morganii</italic> showed a low level of resistance to beta-lactams due to its resistance to ampicillin, amoxicillin, ticarcillin and piperacillin only. It was susceptible to amoxicillin/clavulanic acid, ticarcillin/clavulanic acid, piperacillin/tazobactam, cafalotin, cefamandol, cefoxitin, cefotaxim, ceftazidim, cefpirom, aztreonam, imipenem and ertapenem. This strain was resistant to gentamicin and tobramycin but susceptible to amikacin. It showed also, decreased susceptibility to trimethoprime/sulfamides and rifampicin. The MIC with microbroth dilution technique was 512&#xA0;&#x3BC;g/ml for norfloxacin, 256&#xA0;&#x3BC;g/ml for ofloxacin and ciprofloxacin and 64&#xA0;&#x3BC;g/ml for levofloxacin.</p>
      </sec>
      <sec>
        <title>Detection of PMQR genes</title>
        <p>The PMQR screening with PCR revealed the presence of <italic>qnrD</italic> in <italic>M.morganii</italic> only. None of the other studied Enterobacteria harboured the <italic>qnrD</italic> gene. The sequencing result showed the presence of <italic>qnrD1</italic> in the <italic>M. morganii</italic> isolate. <italic>qnrA, qnrB, qnrS, qnrC, aac-Ib-cr</italic> and <italic>qepA</italic> genes were not found in this strain.</p>
      </sec>
      <sec>
        <title>Conjugation</title>
        <p>The conjugative reaction fails and the <italic>qnrD</italic> gene couldn&#x2019;t be transferred to <italic>E.coli</italic> J53.</p>
      </sec>
      <sec>
        <title>Topoisomerase mutations</title>
        <p>Sequencing of PCR products of QRDRs in <italic>gyrB</italic> and <italic>parC</italic> showed two mutations in the QRDR of <italic>gyr B</italic> at 463 and 464 codons. The first one is an S463A substitution and the second is an S464Y substitution.</p>
        <p>Mutation was found also in the QRDR of <italic>parC</italic> at codon 80. It was an S80I substitution.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The Gram-negative <italic>M. morganii</italic> is found in the environment and as a part of the normal flora of humans. It has been considered as a rare cause of human infections. However, it is an important opportunistic pathogen in urinary tract, soft tissue infections and also in infections following surgery [<xref ref-type="bibr" rid="B12">12</xref>],[<xref ref-type="bibr" rid="B13">13</xref>]. In this case of study, the old age of the patient, the bladder tumor and its resection and the probe introduction after the surgery are risk factors leading to the urinary tract infection with the opportunistic <italic>M. morganii</italic>.</p>
      <p>This <italic>M. morganii</italic> strain was highly resistant to quinolones and <italic>qnrD</italic> was detected. <italic>qnrD</italic> was not found to be self transmissible and it could have spread either on a mobilizable plasmid or on a transferable structure integrated into a conjugative plasmid [<xref ref-type="bibr" rid="B6">6</xref>]. The transfer of quinolone resistance due to <italic>qnrD</italic> is always studied on transformants never on transconjugants. In the study of Hu et al., <italic>Proteus mirabilis</italic> harbouring <italic>qnrD</italic> failed to transfer quinolone resistance to <italic>E.coli</italic> 600 by conjugation [<xref ref-type="bibr" rid="B14">14</xref>]. The MIC of ciprofloxacin in <italic>E.coli</italic> DH10B cells increased in the transformants carring the plasmid pBR322 with the cloned <italic>qnrD</italic> from 0,002&#xA0;&#x3BC;g/ml to 0,06&#xA0;&#x3BC;g/ml (by a factor 32) [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>However, <italic>qnrD</italic> positive clinical strains described so far exhibited a high level of quinolone resistance with ciprofloxacin MIC ranging from 1 to higher then 32&#xA0;&#x3BC;g/ml and they are likely to harbour other quinolone resistance mechanisms [<xref ref-type="bibr" rid="B14">14</xref>],[<xref ref-type="bibr" rid="B15">15</xref>]. Topoisomerase mutations have not been always investigated in <italic>qnr</italic>D positive clinical strains in order to evaluate how both mechanisms interact. The <italic>gyrA</italic> and <italic>parE</italic> primers used to amlify the QRDRs for Enterobacteria were not available for <italic>M. morganii</italic>. The study of Mazzariol A et <italic>al.</italic> couldn&#x2019;t to amplify <italic>gyrA</italic> and <italic>parC</italic> genes in this bacteria and this is due to its unknown genome [<xref ref-type="bibr" rid="B15">15</xref>].</p>
      <p>To date, none of <italic>M. morganii</italic> was described with <italic>gyrB</italic> mutations. In this report, we described for the first time, two new <italic>gyrB</italic> mutations in <italic>M. morganii</italic>. In gram-negative bacilli, <italic>gyrB</italic> mutations are rare in clinical strains and they have been described at positions 426, 431, 447, 463, 464 and 466. The Ser 463Ala mutation has been linked to <italic>Klebsiella oxytoca</italic>[<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>This is the first report of the previous mutation in <italic>qnrD</italic> harbouring <italic>M. morganii</italic>. The Ser 464 Phe mutation has been linked to quinolone resistant <italic>S.enterica</italic>, <italic>P.aeruginosa</italic> and <italic>P.mirabilis</italic>[<xref ref-type="bibr" rid="B16">16</xref>]-[<xref ref-type="bibr" rid="B18">18</xref>]. In this study, the <italic>gyrB</italic> Tyr464 mutation was different from those described previously.</p>
      <p>For <italic>M. morganii,</italic> the first <italic>ParC</italic> mutation was reported in the Tunisian study of Mahrouki et <italic>al.</italic>[<xref ref-type="bibr" rid="B19">19</xref>]. It was an S80I mutation associated to the <italic>qnrS</italic> 1 gene.</p>
      <p>Another <italic>ParC</italic> mutation (S80R) was also described previously in this <italic>Proteeae</italic>[<xref ref-type="bibr" rid="B20">20</xref>]. In this study, we described the first S80I mutation in qnrD-positive <italic>M. morganii</italic>. This type of mutation was already observed in other Enterobacteria but never associated to the <italic>qnrD</italic> gene [<xref ref-type="bibr" rid="B21">21</xref>].</p>
      <p>In summary, we have reported for the first time in Tunisia the rare <italic>qnr</italic>D in <italic>M. morganii</italic> and also found two new <italic>gyrB</italic> mutations (S463A and S464Y) and one <italic>parC</italic> substitution (S80I). In addition to <italic>qnrD</italic> gene, both mutations in <italic>gyrB</italic> and <italic>ParC</italic> could contribute to the high level of resistance to quinolones in this strain. The nosocomial infection caused by this bacterium invites further study of its epidemiologic evolution.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019;contributions</title>
      <p>MNY carried the bacteria collection and typing antibiotic susceptibility, PCR screening, sequence blasting and writing the manuscript. IDR is project designer and co-supervisor of research work. QG Laboratory supervisor, she controlled the analysis, interpretation of data and controlled the manuscript. MM provided the necessary materials for collection, typing and doing the susceptibility tests. MA project designer and general supervisor of research group. MW General supervisor of research experiments and controlled the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mart&#xED;nez-Mart&#xED;nez</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Pascual</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jacoby</surname>
            <given-names>GA</given-names>
          </name>
          <article-title>Quinolone resistance from a transferable plasmid</article-title>
          <source>Lancet</source>
          <year>1998</year>
          <volume>351</volume>
          <fpage>797</fpage>
          <lpage>799</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(97)07322-4</pub-id>
          <pub-id pub-id-type="pmid">9519952</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cavaco</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Hasman</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Aarestrup</surname>
            <given-names>FM</given-names>
          </name>
          <article-title>QnrD, a novel gene conferring transferable quinolone resistance in <italic>Salmonella enterica Serovar Kentucky</italic> and <italic>bovismorbificans</italic> strains of human origin</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>58</volume>
          <fpage>603</fpage>
          <lpage>608</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.00997-08</pub-id>
          <pub-id pub-id-type="pmid">19029321</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Prevalence and dissemination of oqxAB in <italic>Escherichia coli</italic> isolates from animals, farmworkers, and the environment</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2010</year>
          <volume>54</volume>
          <fpage>4219</fpage>
          <lpage>4224</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.00139-10</pub-id>
          <pub-id pub-id-type="pmid">20696876</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Koncan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mazzariol</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kocsis</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Fontana</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lanzafame</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rassu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cornaglia</surname>
            <given-names>M</given-names>
          </name>
          <article-title>First detection in Europe of plasmid-mediated fluoroquinolone resistance <italic>qnrD</italic> determinant</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>S126</fpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-0691.2009.02780.x</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ogbolu</surname>
            <given-names>DO</given-names>
          </name>
          <name>
            <surname>Daini</surname>
            <given-names>OA</given-names>
          </name>
          <name>
            <surname>Ogunledun</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Alli</surname>
            <given-names>AO</given-names>
          </name>
          <name>
            <surname>Webber</surname>
            <given-names>MA</given-names>
          </name>
          <article-title>High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria</article-title>
          <source>Int J Antimicrob Agents</source>
          <year>2011</year>
          <volume>37</volume>
          <fpage>62</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2010.08.019</pub-id>
          <pub-id pub-id-type="pmid">21074376</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Guillard</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cambau</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Neuwirth</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nenninger</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mbadi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brasme</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vernet-Garnier</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Bajolet</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Champsa</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Description of a 2,683-base-pair plasmid containing <italic>qnrD</italic> in two <italic>Providencia rettgeri</italic> isolates</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2011</year>
          <volume>56</volume>
          <issue>1</issue>
          <fpage>565</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.00081-11</pub-id>
          <pub-id pub-id-type="pmid">21986831</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cattoir</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Poirel</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Rotimi</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Soussy</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nordmann</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Multiplex PCR for detection of plasmid-mediated quinolone resistance <italic>qnr</italic> genes in ESBL-producing enterobacterial isolates</article-title>
          <source>J Antimicrobial Chemother</source>
          <year>2007</year>
          <volume>60</volume>
          <fpage>394</fpage>
          <lpage>397</lpage>
          <pub-id pub-id-type="doi">10.1093/jac/dkm204</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Minghua</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Qinglan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Xiaogang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xiaoying</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Xinyu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hooper</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Minggui</surname>
            <given-names>W</given-names>
          </name>
          <article-title>New plasmid-mediated Quinolone resistance gene, <italic>qnrC</italic>, found in a clinical isolate of <italic>Proteus mirabilis</italic></article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <issue>5</issue>
          <fpage>1892</fpage>
          <lpage>1897</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.01400-08</pub-id>
          <pub-id pub-id-type="pmid">19258263</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Park</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Robicsek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jacoby</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Sahm</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hooper</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Prevalence in the United States of <italic>aac(6</italic>_<italic>)</italic>-<italic>Ib</italic>-<italic>cr</italic> encoding a Ciprofloxacin-modifying enzyme</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2006</year>
          <volume>50</volume>
          <issue>11</issue>
          <fpage>3953</fpage>
          <lpage>3955</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.00915-06</pub-id>
          <pub-id pub-id-type="pmid">16954321</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yamane</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wachino</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Arakawa</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Plasmid-mediated <italic>qepA</italic> gene among <italic>Escherichia coli</italic> clinical isolates from Japan</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2008</year>
          <volume>52</volume>
          <issue>4</issue>
          <fpage>1564</fpage>
          <lpage>1566</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.01137-07</pub-id>
          <pub-id pub-id-type="pmid">18285488</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lascols</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Robert</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cattoir</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>B&#xE9;b&#xE9;ar</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cavallo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Podglajen</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ploy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bonnet</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Soussy</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cambau</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Type II topoisomerase mutations in clinical isolates of <italic>Enterobacter cloacae</italic> and other enterobacterial species harbouring the <italic>qnrA</italic> gene</article-title>
          <source>Int J Antimicrob Agents</source>
          <year>2007</year>
          <volume>29</volume>
          <fpage>402</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.11.008</pub-id>
          <pub-id pub-id-type="pmid">17254753</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tsai</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>TH</given-names>
          </name>
          <article-title>CAPD-related Peritonitis caused by <italic>Morganella morganii</italic></article-title>
          <source>PD</source>
          <year>2013</year>
          <volume>33</volume>
          <fpage>104</fpage>
          <lpage>105</lpage>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shia</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ken</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tsao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hsieh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ku</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Whole-genome sequencing and identification of <italic>Morganella morganii</italic> KT pathogenicity-related genes</article-title>
          <source>BMC Genomics</source>
          <year>2012</year>
          <volume>13</volume>
          <issue>Suppl 7</issue>
          <fpage>S4</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-13-S7-S4</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Emergence of <italic>Proteus mirabilis</italic> harboring <italic>bla</italic>KPC-2 and <italic>qnrD</italic> in a Chinese Hospital</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2012</year>
          <volume>56</volume>
          <issue>5</issue>
          <fpage>2278</fpage>
          <lpage>2282</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.05519-11</pub-id>
          <pub-id pub-id-type="pmid">22354308</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mazzariol</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kocsis</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Koncan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kocsis</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lanzafame</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cornaglia</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Description and plasmid characterization of <italic>qnrD</italic> determinants in Proteus mirabilis and <italic>Morganella morganii</italic></article-title>
          <source>Clin Microbiol Infect</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>E46</fpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03728.x</pub-id>
          <pub-id pub-id-type="pmid">22192340</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gensberg</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>YF</given-names>
          </name>
          <name>
            <surname>Piddock</surname>
            <given-names>LJ</given-names>
          </name>
          <article-title>A novel <italic>gyrB</italic> mutation in a fluoroquinolone-resistant clinical isolate of <italic>Salmonella typhimurium</italic></article-title>
          <source>FEMS Microbiol Lett</source>
          <year>1995</year>
          <volume>132</volume>
          <fpage>57</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1574-6968.1995.tb07810.x</pub-id>
          <pub-id pub-id-type="pmid">7590165</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mouneimne</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Robert</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jarlier</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Cambau</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Type II topoisomerase mutations in ciprofloxacin-resistant strains of <italic>Pseudomonas aeruginosa</italic></article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>1999</year>
          <volume>43</volume>
          <fpage>62</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">9869566</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Weigel</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Anderson</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Tenover</surname>
            <given-names>FC</given-names>
          </name>
          <article-title>DNAgyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in <italic>Proteus mirabilis</italic></article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2002</year>
          <volume>46</volume>
          <fpage>2582</fpage>
          <lpage>2587</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.46.8.2582-2587.2002</pub-id>
          <pub-id pub-id-type="pmid">12121936</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mahrouki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bourouis</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chihi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ouertani</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ferjani</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Moussa</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Barguellil</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Belhadj</surname>
            <given-names>O</given-names>
          </name>
          <article-title>First characterisation of plasmid-mediated quinolone resistance-qnrS1 co-expressed <italic>bla</italic><sub><italic>CTX-M-15</italic></sub> and <italic>bla</italic><sub><italic>DHA-1</italic></sub> genes in clinical strain of <italic>Morganella morganii</italic> recovered from a Tunisian Intensive Care Unit</article-title>
          <source>Indian J Med Microbiol</source>
          <year>2012</year>
          <volume>30</volume>
          <fpage>437</fpage>
          <lpage>441</lpage>
          <pub-id pub-id-type="doi">10.4103/0255-0857.103765</pub-id>
          <pub-id pub-id-type="pmid">23183469</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Andres</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lucero</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Soler-Bistu&#xE9;</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Guerriero</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Albornoz</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Tran</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zorreguieta</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Galas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Corso</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tolmasky</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Petroni</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Differential distribution of plasmid-mediated Quinolone resistance genes in clinical enterobacteria with unusual phenotypes of Quinolone susceptibility from Argentina</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2013</year>
          <volume>57</volume>
          <issue>6</issue>
          <fpage>2467</fpage>
          <lpage>2475</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.01615-12</pub-id>
          <pub-id pub-id-type="pmid">23478955</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nam</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Prevalence and molecular characterization of Fluoroquinolone-resistant <italic>Escherichia coli</italic> isolated from diarrheic cattle in Korea</article-title>
          <source>J Vet Med Sci</source>
          <year>2010</year>
          <volume>72</volume>
          <issue>5</issue>
          <fpage>611</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="doi">10.1292/jvms.08-0302</pub-id>
          <pub-id pub-id-type="pmid">20009431</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
